Table 3.

Rituximab administration.

No.	Disease duration before RTX (d)	The duration between initial RTX infusion to last follow-up(m)	The interval between first infusion of rituximab and the first sign of clinical improvement (d)	Infusion regimen	Ongoing treatments at last clinic visit
1	541	24	18	375 mg/m2/ week × 4	None
2	60	27	48	375 mg/m2/ week × 4	None
3	50	3.5	32	375 mg/m2/ week × 4	None
4	52	12.5	10	375 mg/m2/ week × 3	None
5	124	6	No response	375 mg/m2/ week × 4	None
6	54	1.7	10	375 mg/m2/ week × 4	Oral steroids(tapering)
7	34	2.6	16	375 mg/m2/ week × 3	Mycophenolate Mofetil
8	83	37	11	375 mg/m2/ week × 4	None